Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks

BACKGROUND: Since traditional drug research and development is often time-consuming and high-risk, there is an increasing interest in establishing new medical indications for approved drugs, referred to as drug repositioning, which provides a relatively low-cost and high-efficiency approach for drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Song, Yinglong, Guan, Jihong, Luo, Libo, Zhuang, Ziheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259862/
https://www.ncbi.nlm.nih.gov/pubmed/28155639
http://dx.doi.org/10.1186/s12859-016-1336-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259862/
https://www.ncbi.nlm.nih.gov/pubmed/28155639
http://dx.doi.org/10.1186/s12859-016-1336-7

Ejemplares similares